Investigators found data to support the need to tailor individual treatment strategies to improve outcomes in rheumatoid arthritis, which includes further studies to identify biomarkers and patient education about testing and expectations for treatment.
Rheumatologists are expected to play an increasing role in the diagnosis and management of patients with cancer with immune checkpoint inhibitor-related rheumatic diseases.
Researchers found data that showed automated intelligence-based techniques are beneficial in detecting cardiovascular disease caused by the genetic makeup of patients with rheumatoid arthritis.
Understanding genetic factors associated with psoriatic arthritis pathogenesis will support targeted development of new therapies.
Citing recommendations and guidelines from worldwide government agencies and organizations, researchers believe that the consensus supports the safety of vaccinations for patients with rheumatoid arthritis who are undergoing treatment with disease-modifying antirheumatic drugs.
IL-17A inhibitors offer new options in patients with ankylosing spondylitis beyond TNFi agents.
Recent data show that men with rheumatoid arthritis may not fully benefit from self-management programs.
Tools for accurate measurement of serum uric acid level, particularly at low levels, is essential for early gout diagnosis, prompt treatment initiation, and monitoring of treatment effectiveness.
Recent data suggest that the link between circadian rhythms of RA symptoms and the chronotherapy of RA is promising.